| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $61.9M | $58.1M | $124.1M |
| YoY Revenue Growth % | +6.6% | -53.2% | — |
| Gross Profit | $18.9M | $16.6M | — |
| Gross Margin % | 30.6% | 28.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.3M | -$13.3M | -$28.7M |
| Operating Margin % | -19.8% | -22.8% | -23.1% |
| Net Income (GAAP) | -$11.5M | -$13.7M | -$26.4M |
| EBITDA (Normalized) | -$11.3M | -$12.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.2M | $18.3M | $31.9M |
| Capital Expenditures (CapEx) | $1.2M | $932.0K | — |
| Free Cash Flow (FCF) | -$3.3M | $17.4M | $31.9M |
| FCF Margin % | -5.4% | 29.9% | 25.7% |
| Return on Invested Capital (ROIC %) | -11.8% | -13.7% | — |
| Cash & Short-Term Equivalents | $35.2M | $51.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $117.5M | $127.8M | — |